Literature DB >> 22198743

Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine.

Hongmei Xu1, Xuetao Cao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22198743     DOI： 10.1007/s11684-011-0172-4

Source DB:  PubMed          Journal:  Front Med        ISSN： 2095-0217            Impact factor:   4.592


× No keyword cloud information.
  61 in total

Review 1.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 2.  Stress for maintaining memory: HSP70 as a mobile messenger for innate and adaptive immunity.

Authors:  Taoyong Chen; Xuetao Cao
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

3.  Landmark approval for Dendreon's cancer vaccine.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2010-06       Impact factor: 54.908

Review 4.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

Review 5.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Authors:  Paul J Tacken; I Jolanda M de Vries; Ruurd Torensma; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

Review 6.  Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Authors:  Lisa H Butterfield; A Karolina Palucka; Cedrik M Britten; Madhav V Dhodapkar; Leif Håkansson; Sylvia Janetzki; Yutaka Kawakami; Thomas-Oliver Kleen; Peter P Lee; Cristina Maccalli; Holden T Maecker; Vernon C Maino; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; Graham Pawelec; Douglas M Potter; Licia Rivoltini; Lupe G Salazar; Dolores J Schendel; Craig L Slingluff; Wenru Song; David F Stroncek; Hideaki Tahara; Magdalena Thurin; Giorgio Trinchieri; Sjoerd H van Der Burg; Theresa L Whiteside; Jon M Wigginton; Francesco Marincola; Samir Khleif; Bernard A Fox; Mary L Disis
Journal:  Clin Cancer Res       Date:  2011-05-10       Impact factor: 12.531

7.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.

Authors:  Thomas Luft; Michael Jefford; Petra Luetjens; Tracey Toy; Hubertus Hochrein; Kelly-Anne Masterman; Charlie Maliszewski; Ken Shortman; Jonathan Cebon; Eugene Maraskovsky
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 8.  Cancer immunotherapy with mRNA-transfected dendritic cells.

Authors:  Eli Gilboa; Johannes Vieweg
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

9.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

10.  Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming.

Authors:  Alfonso MartIn-Fontecha; Silvia Sebastiani; Uta E Höpken; Mariagrazia Uguccioni; Martin Lipp; Antonio Lanzavecchia; Federica Sallusto
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307
View more
  11 in total

Review 1.  The exosomes in tumor immunity.

Authors:  Yanfang Liu; Yan Gu; Xuetao Cao
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

Review 2.  Intratumoral dendritic cells in the anti-tumor immune response.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2015-01-19       Impact factor: 11.530

Review 3.  Nanoparticle-based approaches to target the lymphatic system for antitumor treatment.

Authors:  Xingzhou Peng; Junjie Wang; Feifan Zhou; Qian Liu; Zhihong Zhang
Journal:  Cell Mol Life Sci       Date:  2021-05-08       Impact factor: 9.261

4.  Dendritic cells serve as a "Trojan horse" for oncolytic adenovirus delivery in the treatment of mouse prostate cancer.

Authors:  Zhao-Lun Li; Xuan Liang; He-Cheng Li; Zi-Ming Wang; Tie Chong
Journal:  Acta Pharmacol Sin       Date:  2016-06-27       Impact factor: 6.150

5.  Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.

Authors:  Brendon J Coventry; Martin L Ashdown
Journal:  Cancer Manag Res       Date:  2012-05-28       Impact factor: 3.989

6.  microRNA-155 deficiency impairs dendritic cell function in breast cancer.

Authors:  Junfeng Wang; Stephen Iwanowycz; Fang Yu; Xuemei Jia; Shuilong Leng; Yuzhen Wang; Wei Li; Shiang Huang; Walden Ai; Daping Fan
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

7.  Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling.

Authors:  Zu-Quan Hu; Hui Xue; Jin-Hua Long; Yun Wang; Yi Jia; Wei Qiu; Jing Zhou; Zong-Yao Wen; Wei-Juan Yao; Zhu Zeng
Journal:  Int J Mol Sci       Date:  2016-10-31       Impact factor: 5.923

Review 8.  Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy.

Authors:  Jianbo Jia; Yi Zhang; Yan Xin; Cuijuan Jiang; Bing Yan; Shumei Zhai
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

9.  Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.

Authors:  Honglin Jin; Yuan Qian; Yanfeng Dai; Sha Qiao; Chuan Huang; Lisen Lu; Qingming Luo; Jing Chen; Zhihong Zhang
Journal:  Theranostics       Date:  2016-09-02       Impact factor: 11.556

10.  Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.

Authors:  Sheikh Tasnim Jahan; Sams Ma Sadat; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2018-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.